BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27421050)

  • 1. Test and treat: the early experiences in a clinic serving women at high risk of HIV infection in Kampala.
    Mbonye M; Seeley J; Nalugya R; Kiwanuka T; Bagiire D; Mugyenyi M; Namale G; Mayanja Y; Kamali A
    AIDS Care; 2016; 28 Suppl 3():33-8. PubMed ID: 27421050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Test and Treat' Among Women at High Risk for HIV-infection in Kampala, Uganda: Antiretroviral Therapy Initiation and Associated Factors.
    Mayanja Y; Kamacooko O; Bagiire D; Namale G; Kaleebu P; Seeley J
    AIDS Behav; 2018 Mar; 22(3):1053-1061. PubMed ID: 29127534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
    Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
    Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
    Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
    BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stigma trajectories among people living with HIV (PLHIV) embarking on a life time journey with antiretroviral drugs in Jinja, Uganda.
    Mbonye M; Nakamanya S; Birungi J; King R; Seeley J; Jaffar S
    BMC Public Health; 2013 Sep; 13():804. PubMed ID: 24010761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda-A qualitative study.
    Ross J; Ingabire C; Umwiza F; Gasana J; Munyaneza A; Murenzi G; Nsanzimana S; Remera E; Akiyama MJ; Anastos KM; Adedimeji A
    PLoS One; 2021; 16(5):e0251645. PubMed ID: 33984044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to HIV care in Uganda and implications for universal test-and-treat: a qualitative study.
    Lofgren SM; Tsui S; Atuyambe L; Ankunda L; Komuhendo R; Wamala N; Sadiq A; Kirumira P; Srishyla D; Flynn A; Pastick KA; Meya DB; Nakasujja N; Porta C
    AIDS Care; 2022 May; 34(5):597-605. PubMed ID: 34314261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Can't you initiate me here?": Challenges to timely initiation on antiretroviral therapy among methadone clients in Dar es Salaam, Tanzania.
    Saleem HT; Mushi D; Hassan S; Bruce RD; Cooke A; Mbwambo J; Lambdin BH
    Int J Drug Policy; 2016 Apr; 30():59-65. PubMed ID: 26831364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding implementation barriers in the national scale-up of differentiated ART delivery in Uganda.
    Zakumumpa H; Rujumba J; Kwiringira J; Katureebe C; Spicer N
    BMC Health Serv Res; 2020 Mar; 20(1):222. PubMed ID: 32183796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What causes non-adherence among some individuals on long term antiretroviral therapy? Experiences of individuals with poor viral suppression in Uganda.
    Bukenya D; Mayanja BN; Nakamanya S; Muhumuza R; Seeley J
    AIDS Res Ther; 2019 Jan; 16(1):2. PubMed ID: 30665440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to starting ART and how they can be overcome: individual and operational factors associated with early and late start of treatment.
    Parkes-Ratanshi R; Bufumbo L; Nyanzi-Wakholi B; Levin J; Grosskurth H; Lalloo DG; Kamali A
    Trop Med Int Health; 2010 Nov; 15(11):1347-56. PubMed ID: 20955498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol consumption and high risk sexual behaviour among female sex workers in Uganda.
    Mbonye M; Rutakumwa R; Weiss H; Seeley J
    Afr J AIDS Res; 2014; 13(2):145-51. PubMed ID: 25174631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Children will always be children': exploring perceptions and experiences of HIV-positive children who may not take their treatment and why they may not tell.
    Kawuma R; Bernays S; Siu G; Rhodes T; Seeley J
    Afr J AIDS Res; 2014; 13(2):189-95. PubMed ID: 25174636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
    Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
    AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Then her neighbour will not know her status': how health providers advocate antiretroviral therapy under universal test and treat.
    Pell C; Reis R; Dlamini N; Moyer E; Vernooij E
    Int Health; 2019 Jan; 11(1):36-41. PubMed ID: 30137387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding Antiretroviral Treatment Adherence Among HIV-Positive Women at Four Postpartum Time Intervals: Qualitative Results from the Kabeho Study in Rwanda.
    Gill MM; Umutoni A; Hoffman HJ; Ndatimana D; Ndayisaba GF; Kibitenga S; Mugwaneza P; Asiimwe A; Bobrow EA
    AIDS Patient Care STDS; 2017 Apr; 31(4):153-166. PubMed ID: 28358624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa.
    Iwuji C; Chimukuche RS; Zuma T; Plazy M; Larmarange J; Orne-Gliemann J; Siedner M; Shahmanesh M; Seeley J
    PLoS One; 2020; 15(9):e0239513. PubMed ID: 32970730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Even if you're HIV-positive there's life after if you take your medication": experiences of people on long-term ART in South Africa: a short report.
    Hendrickson C; Moolla A; Maskew M; Long L; Fox MP; Sanne I; Majuba P; Pascoe S
    AIDS Care; 2019 Aug; 31(8):973-978. PubMed ID: 30913899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the cultural context of HIV stigma on antiretroviral therapy adherence among people living with HIV/AIDS in southwest Nigeria.
    Okoror TA; Falade CO; Olorunlana A; Walker EM; Okareh OT
    AIDS Patient Care STDS; 2013 Jan; 27(1):55-64. PubMed ID: 23305262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.